EcoDrugPlus

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSSTUG00000048249
Gene Symbol: ESRRGA
1 Cross references
197 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSTUG00000030289
Gene Symbol: XPO1
3 Cross references
218 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSTUG00000018409
Gene Symbol: XPO1
1 Cross references
208 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSTUG00000022024
Gene Symbol: XPO1
3 Cross references
208 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSTUG00000040259
Gene Symbol: XPO1
3 Cross references
218 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSSTUG00000041654
Gene Symbol: LOC115176422
3 Cross references
265 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSSTUG00000037851
Gene Symbol: LOC115176388
3 Cross references
265 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSTUG00000000941
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSSTUG00000048597
Gene Symbol: FNTB
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSTUG00000005535
Gene Symbol: FGFR1
3 Cross references
197 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSTUG00000043321
Gene Symbol: FGFR1
3 Cross references
198 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSSTUG00000016883
Gene Symbol: LOC115200093
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).